B.C. reviews funding for costly cholesterol drug alternative
B.C. is deciding whether to fund Leqvio, a $9,000-per-year drug for genetic high cholesterol patients intolerant to statins. The decision follows new national recommendations.
Category : Search result: BC pharmacare
HIV Cases Rise 35% in Canada, Expert Urges Funding
Dr. Julio Montaner warns that underfunding HIV treatment and prevention now will cost Canada more later. Cases are rising despite proven tools like TasP and PrEP.
Health Minister noncommittal on pharmacare report
Health Minister Marjorie Michel states the expert pharmacare report is not binding, leaving the future of a national drug plan uncertain. Learn about the implications.
Health Minister Dismisses Key Pharmacare Recommendation
Health Minister Marjorie Michel rejects crucial pharmacare recommendation from expert panel, raising questions about Canada's drug coverage future. Learn what this means for healthcare.
Pharmacare Advisory Committee Report Going Public
The Canadian government prepares to release the pharmacare advisory committee's findings, marking a pivotal moment for national prescription drug coverage. Learn what this means for healthcare.
Page 1 of 1